Doz

Hepatitis B immune globulin (human)

ایمونوگلوبولین هپاتیت B (HBIG)

⚠ Unverified

🦠 Antiinfectives For Systemic UseSpecific immune globulin

🤰 Pregnancy:Use with caution👶 Children:Safety not established 🇮🇷 Registered in Iran 🇺🇸 FDA approved (BLA) BLA101146ATC J06BB04

Market / country: 🇺🇸 USA

HyperHEP B (US)

🧮 Dose calculator

Hepatitis B exposure (needlestick, infant of HBsAg-positive mother) · Regimen source: FDA HyperHEP B · Dosage and Administration

  • • As soon as possible, preferably within 24 h (value after 7 days unclear; within 2 weeks for sexual exposure). Start or complete the hepatitis B vaccine series per label Table 1. FDA HyperHEP B · Dosage and Administration

Enter age and weight.

🛡️ Safety & information

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA HyperHEP B · Pregnancy

    “Animal reproduction studies have not been conducted with Hyper HEP B .”
  • 🤱 BreastfeedingNo data

    The source for this drug has no section for this group.

  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA HyperHEP B · Pediatric Use

    “Safety and effectiveness in the pediatric population have not been established.”
  • 👴 Older adultsNo data

    The source for this drug has no section for this group.

  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav